A team of scientists from the Institute of Bioorganic Chemistry RAS, Xenetic Biosciences Inc., OJSC Pharmsynthez and Center of multiple sclerosis and AID of St. Petersburg City Clinical Hospital №31 has created a new form of the vaccine used for the treatment of one of the most severe neurodegenerative autoimmune diseases. The drug has successfully passed pre-clinical trials and two clinical stages. If the results of the third stage of the clinical trials would be positive, the dug shall officially be passed into circulation to be used for the treatment of patients with multiple sclerosis.

News

  • Biology Day II successfully held at the IBCh science news VI.24

    Apart from being the ideal time for relaxing, travelling and organizing children's camps, summer time also presents an opportunity to gain the kind of valuable knowledge that you will not find in school, not read in a high school textbook, nor are you ever going to hear it on TV. On June 22, researchers from the Institute of Bioorganic Chemistry (IBCh RAS) shared such knowledge during Biology Day, a popular science event that was organized at the Institute of Bioorganic Chemistry. This is the second time that such an event is taking place, at the initiative of the Council of Young Scientists.

  • Scientists at the IBCh RAS have developed a drug for the treatment of multiple sclerosis science news VI.23

    A team of scientists from the Institute of Bioorganic Chemistry RAS, Xenetic Biosciences Inc., OJSC Pharmsynthez and Center of multiple sclerosis and AID of St. Petersburg City Clinical Hospital №31 has created a new form of the vaccine used for the treatment of one of the most severe neurodegenerative autoimmune diseases. The drug has successfully passed pre-clinical trials and two clinical stages. If the results of the third stage of the clinical trials would be positive, the dug shall officially be passed into circulation to be used for the treatment of patients with multiple sclerosis. The results are published in the Neurotherapeutics journal.

  • Scientists at the IBCh have created a database for scorpion venom science news VI.20

    Researchers at the Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IBCh RAS) have created a database for peptide toxins from scorpion venom – Kalium. This database shall enable scientists to systematize information on the molecules that block potassium channels. In addition, such a database shall be a useful tool to conduct further studies on the channels themselves, which are today considered as pharmacological targets for certain autoimmune, oncological and neurodegenerative diseases. They published the results of their work in the magazine – Database: The Journal of Biological Databases and Curation.

Events